Primary Total: $52,502,661
Total: $42,538,086
Primary Total: $39,077,134
Total: $220,002
Primary Total: $220,002
*A Phase II Dose-Ranging and Comparative Study of the Safety and Efficacy of Gadobenate Dimeglumine in Magnetic Resonance Imaging in Patients with Focal Liver Lesions, (429683), Bracco Diagnostics, $2.
*Contrast Media in MRI, (425890), Bracco Diagnostics, $220,000 (adjustment).
For questions regarding listings, contact Ms. Deborah Davis, director of the Office of Sponsored Projects Administration, 214 Kinkead Hall, 0057, phone 257-8311. (ddavis@pop.uky.edu )
Last Updated: 6/30/03